Chromogenic anti-FXa assay calibrated with low molecular weight heparin in patients treated with rivaroxaban and apixaban
Clinical application of rivaroxaban and apixaban does not require therapeutic monitoring. Commercial anti-activated factor X (anti-FXa) inhibition methods for all anti-FXa drugs are based on the same principle, so there are attempts to evaluate potential clinical application of heparin-calibrated an...
| Permalink: | http://skupni.nsk.hr/Record/nsk.NSK01001102500/Description |
|---|---|
| Matična publikacija: |
Biochemia medica (Online) 30 (2020), 1 ; str. 74-82 |
| Glavni autori: | Margetić, Sandra (Author), Ćelap, Ivana, Delić-Brkljačić, Diana, Pavlović, Nikola, liječnik, Šupraha Goreta, Sandra, Kobasić, Ivana, Lovrenčić-Huzjan, Arijana, Bašić Kes, Vanja |
| Vrsta građe: | e-članak |
| Jezik: | eng |
| Predmet: | |
| Online pristup: |
https://doi.org/10.11613/BM.2020.010702 Biochemia medica (Online) Hrčak |